筛选条件 共查询到34条结果
排序方式
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a tenacious pathogen that has latently infected one third of the world'......

Characterization of chronic relapsing antibody mediated arthritis in mice with a mutation in Ncf1 causing reduced oxidative burst

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Rheumatoid arthritis (RA) is a chronic autoimmune disorder affecting joints with a hallmark of autoantibody production. Mannan-enhanced collagen type ......

CRISPR-Cas systems target endogenous genes to impact bacterial physiology and alter mammalian immune responses

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

CRISPR-Cas systems are an immune defense mechanism that is widespread in archaea and bacteria against invasive phages or foreign genetic elements. In ......

An overview of PROTACs: a promising drug discovery paradigm

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Proteolysis targeting chimeras (PROTACs) technology has emerged as a novel therapeutic paradigm in recent years. PROTACs are heterobifunctional molecu......

Optimization of miR-22 expression cassette for rAAV delivery on diabetes

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

MicroRNA-22 (miR-22) was suggested to be important for type 2 diabetes but its functions for this disease remained unclear. Recombinant adeno-associat......

Distribution and characterization of extrachromosomal circular DNA in colorectal cancer

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Extrachromosomal circular DNA (eccDNA) has been shown to play an important role in the amplification of tumor genes and the maintenance of intra-tumor......

Development of therapeutic antibodies for the treatment of diseases

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Since the first monoclonal antibody drug, muromonab-CD3, was approved for marketing in 1986, 165 antibody drugs have been approved or are under regula......

Vesicle trafficking and vesicle fusion: mechanisms, biological functions, and their implications for potential disease therapy

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Intracellular vesicle trafficking is the fundamental process to maintain the homeostasis of membrane-enclosed organelles in eukaryotic cells. These or......

Human Identical Sequences, hyaluronan, and hymecromone the new mechanism and management of COVID-19

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

COVID-19 caused by SARS-CoV-2 has created formidable damage to public health and market economy. Currently, SARS-CoV-2 variants has exacerbated the tr......

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

Triple negative breast cancer (TNBC) is a subtype of breast cancer, with estrogen receptor, human epidermal growth factor receptor 2 and progesterone ......

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

The discovery and development of the CRISPR/Cas system is a milestone in precise medicine. CRISPR/Cas nucleases, base-editing (BE) and prime-editing (......

Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies

期刊: MOLECULAR BIOMEDICINE, 2022; 3 (1)

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading globally and continues to rage, posing a s......

共34条页码: 1/3页15条/页